Risk of recurrent venous thromboembolism in patients with autoimmune diseases : data from the Registro Informatizado de Enfermedad TromboEmbólica (RIETE) registry

Jaime Borjas Howard, Pablo Ruiz-Sada, Karina de Leeuw, Luciano López-Jiménez, Carme Font, Pablo Javier Marchena, Olga Madridano, Philippe Debourdeau, Karina Meijer, Manuel Monreal

Producció científica: Contribució a revistaArticleRecercaAvaluat per experts

8 Cites (Scopus)

Resum

Autoimmune disease is a risk factor for first incident venous thromboembolism (VTE). However, data on the risk of recurrent VTE in people with autoimmune disease is sparse. We explored the risk of recurrent VTE using the RIETE registry, comparing people with autoimmune disease (n = 1305) to those without (n = 50608). Overall rates were 6.5 and 5.1 recurrent VTE/100 years for patients with autoimmune disease vs controls, respectively. After adjustment for sex and unprovoked/provoked VTE yielded an adjusted hazard ratio of 1.29 (95%CI 1.03-1.62). The analysis was limited by short median follow up time (161 days overall), precluding definitive conclusions on recurrent VTE risks.
Idioma originalAnglès
Pàgines (de-a)195-199
Nombre de pàgines5
RevistaBritish Journal of Haematology
Volum194
DOIs
Estat de la publicacióPublicada - 2021

Fingerprint

Navegar pels temes de recerca de 'Risk of recurrent venous thromboembolism in patients with autoimmune diseases : data from the Registro Informatizado de Enfermedad TromboEmbólica (RIETE) registry'. Junts formen un fingerprint únic.

Com citar-ho